Samatha J Busfield

Title: Innovator Spotlight: Samatha J. Busfield

Introduction

Samatha J. Busfield, an accomplished inventor based in Maddington, Australia, has made significant contributions to the field of biotechnology. With one patented innovation under his belt, Busfield's work primarily focuses on advancing our understanding of glycoprotein V1 and its applications in medical science.

Latest Patents

Busfield's notable patent, titled "Glycoprotein VI antibodies and uses thereof," encompasses isolated nucleic acid molecules and polypeptide molecules encoding glycoprotein V1, a crucial component in platelet-collagen interactions. His invention offers a range of solutions, including antisense nucleic acid molecules, expression vectors, and host cells designed for introducing these vectors. Additionally, the patent involves non-human transgenic animals that incorporate or disrupt the nucleic acid molecules disclosed. It further details isolated polypeptides, fusion polypeptides, antigenic peptides, and antibodies. The invention also outlines various diagnostic, screening, and therapeutic methods employing the compositions created.

Career Highlights

Samatha J. Busfield is associated with Millennium Pharmaceuticals Limited, a leading company in biotechnology research. His role within the organization underscores his commitment to advancing health solutions through innovative discoveries.

Collaborations

Throughout his career, Busfield has collaborated with esteemed colleagues like Jean-Luc Villeval and Martine Jandrot-Perrus. These partnerships have enabled him to expand his research capabilities and enhance the impact of his inventions.

Conclusion

Samatha J. Busfield is a notable figure in the realm of biotechnology, whose innovation in glycoprotein VI antibodies exemplifies the intersection of research and practical application. His dedication to advancing medical science through patents not only highlights his inventiveness but also serves as an inspiration for future innovators in the field.